Did you mean: HERMANN v. WYETH et al ?

en.wikipedia.org/wiki/Bruesewitz_v._Wyeth

Bruesewitz v. Wyeth, 562 U.S. 223 (2011), is a United States Supreme Court case that decided whether a section of the National Childhood Vaccine Injury Act of 1986 preempts all vaccine design defect claims against vaccine manufacturers .

caselaw.findlaw.com/us-supreme-court/09-152.html

Case opinion for US Supreme Court BRUESEWITZ ET AL. v. ... It granted Wyeth summary judgment, holding that the relevant Pennsylvania law was preempted ...

www.oyez.org/cases/2010/09-152

Oct 12, 2010 ... Bruesewitz v. ... Wyeth, Inc., fka Wyeth Laboratories, et al. ... The Bruesewitzes filed a lawsuit against Wyeth in state court in Pennsylvania.

www.ncbi.nlm.nih.gov/pmc/articles/PMC2546455

LPS and SE were significantly different than placebo for all active treatments (p ... Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK. .... Eszopiclone 2.5 mg also demonstrated significant differences versus .... Vanda, and Wyeth-Ayerst; has consulted for Aventis, Boehringer Ingelheim, ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC1978328

Zammit G; Erman M; Wang-Weigand S; Sainati S; Zhang J; Roth T. Evaluation of the .... All subjects who received at least 1 dose of study medication were included in the intent-to-treat analysis. .... PSG-determined latency to persistent sleep: ramelteon vs placebo treatments. ..... Brzezinski A, Vangel MG, Wurtman RJ, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC2045706

Modafinil was well tolerated versus placebo, with headache (34% vs 23%, respectively), nausea (11% vs 3%), and ... Roth T; Schwartz JRL; Hirshkowitz M et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC2603489

37.8 (3.4) min for placebo, (P < 0.0001 for both doses vs placebo), and by 51.7 ( 3.4) min (P = 0.01) and 48.0 (3.6) min ...... McCall WV, Erman M, Krystal AD, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC518986

Sleepiness Versus Sleeplessness: Shift Work and Sleep Disorders in the Primary Care Setting .... [PubMed]; Hoddes E, Zarcone V, and Smythe H. et al. ..... [ PubMed]; Schwartz JRL, Hirshkowitz M, and Erman MK. et al. ... GlaxoSmithKline, Sanofi-Synthelabo, and Wyeth and is a member of the speakers or advisory boards ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3630939

Jul 20, 2010 ... Zaleplon is a pyrazolopyrimidine hypnotic used for the treatment of insomnia. Zaleplon binds preferentially at the α1β2γ2 subunit of gamma ...